DIAGENS Leads Medical AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets
iMed-6.0 brings multimodal reasoning to medical imaging and powers a multi-task CT model, while zero-code tools support specialty AI development. HONG KONG, Nov. 12, 2026 /PRNewswire/ -- DIAGENS (HKEX: 2526) today announced benchmark results for iMed-6.0, the latest generation of its...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.